Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.680
+0.100 (6.33%)
At close: Jun 26, 2026, 4:00 PM EDT
1.640
-0.040 (-2.38%)
After-hours: Jun 26, 2026, 6:58 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $71.91 million as of June 26, 2026. Its market cap has increased by 80.57% in one year.
Market Cap
71.91M
Enterprise Value
-23.42M
1-Year Change
80.57%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $71.91M, a decrease of -69.42%. That is a compound annual growth rate of -27.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 71.91M | -5.45% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 76.75M |
| Elicio Therapeutics | 76.29M |
| Gain Therapeutics | 74.64M |
| Annovis Bio | 73.17M |
| Edesa Biotech | 72.83M |
| XBiotech | 70.73M |
| Pliant Therapeutics | 70.05M |
| BeyondSpring | 68.67M |